• Skip to main content
  • Skip to footer
Eco Friendly CBD OIL

Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

  • Home
  • CBD Health
  • Cannabis News
  • Contact

Articles

NFL Players Fumble Investment in Southern California Cannabis Business

August 16, 2021 by CBD OIL

On July 21, 2021, NFL superstar wide receiver Julio Jones was named as the lead defendant in a 12-count civil fraud, conversion of assets, breach of contract, and breach of fiduciary duty lawsuit filed in Los Angeles Superior Court relating to a cannabis cultivation operation he co-owns. After being traded from the Atlanta Falcons to the Tennessee Titans this offseason, swapping his black and red jersey for a red, white, and blue one, his focus will be on the color green, as in the color of all the money that he is going to need to pay legal fees.

The case is titled Genetixs, LLC v. Julio Jones, followed by nine other individual and entity-named-defendants including retired Falcon receiver Roddy White. (White is listed individually in the charging document by his formal name, Sharod White.)

Additionally, White’s Mississippi LLC, “SLW Holdings,” is the fifth defendant in the civil case. Jones and White, through White’s LLC, had invested millions of dollars to start and operate a Southern California grow facility, Genetixs. The NFL players, through the holding company, shared a fractionalized ownership interest in the cultivation business with other Genetixs company members. In sum, the cultivation business, Genetixs, operated by the man Jones and White installed as the grow house’s chairman, is now suing the players and others involved in the business.

The 26-page civil complaint (also referred to as the “July 2021 lawsuit”) has been circulating across the Internet and the allegations are incendiary. Genetixs, a California LLC, which operated a grow house in Desert Hot Springs, Calif., has charged that each of civil defendants named in the case participated in a scheme that diverted over $3 million of cannabis a month from March to July 2021 from the Genetixs’ grow facility.

The accusations include claims that associates of Jones, White and others involved in Genetixs’ operations had siphoned off “400 to 2000 pounds of cannabis” through a hole in the wall of Genetixs’ Desert Hot Springs grow facility during an almost six-month period.

It also is alleged that Jones and White, and others, “facilitated” the dissipation of millions of dollars of what should have been Genetixs’ proceeds, and even enabled a former Genetixs employee (who had been hired by the LLC members on day one to build out and manage the grow site and was then fired a year later) to stay on, with family, as squatters at the facility.

Jones and White, over two thousand miles from California, have not been accused of committing the misconduct themselves. The legal language of the July 2021 complaint accuses the NFL players, from afar, with aiding and abetting and “conspiring” with the errant grow house squatters.

Philadelphia’s Drexel University LeBow business school professor Stacy Kline, who teaches Best Business Practices of the Cannabis Industry, in discussing the allegations contained solely in the complaint, was stunned by the description of Genetixs’ gross mismanagement.

“The complaint describes a total lack of oversight for the cannabis business venture and the absence of any internal controls,” Kline stated to Cannabis Business Times. “Where were the security cameras that grow sites are, in many states, required to have? How did so many people who created and were to manage the business abdicate their professional and fiduciary duties to the ongoing concern?”

 Inexperience and Lack of Due Diligence Results in Poor Business Outcomes

There is no way to read the July 2021 complaint (whether any of the allegations are ever proven up at trial) without drawing the conclusion that the wannabe cannabis business investor-partner-member-managers had no cannabis-specific business plan and failed to consult or heed the advice of experienced cannabis business experts before starting a cultivation operation. It’s abundantly clear that the NFL players, like many budding entrepreneurs, got into a business they knew next to nothing about. They both admitted as much in court documents.

 

SLW Holdings v. Freeman by sandydocs

 

A document in a related civil matter (discussed a bit later) and signed under oath by Jones just three weeks before the filing of the Genetixs lawsuit, demonstrates this point. It proves that a bad and ill-conceived cannabis-business-beginning will certainly lead to an ill-fated and often costly ending.

Jones’ account of how he and his friend and former teammate, Roddy White, came to invest “in the cannabis space” is an example of why one  should not invest in cannabis without doing a great deal of research and preparation:

 

“In the summer of 2019, Jones, living in Atlanta, came to Los Angeles for a visit, and while socializing at restaurants and clubs, was approached by someone from Los Angeles named “Al” who had a “proposition” for Jones to invest in cannabis. Based on what was related, Jones believed it would be a “great opportunity to make legal money outside of [his] profession.” 

Jones returned to Georgia and Al from Los Angeles called and texted Jones “about investing in cannabis.” One day, Jones flew back for a cannabis meeting at Al’s office (location not specified). There Jones met future Genetixs’ chairman, Lamarr House, and other men with whom he would ultimately partner at Genetixs.

At some point that day, House urged Jones to not work with Al because Al “did not have his stuff together.” Instead, (as Jones recounts) House urged Jones to do a business deal with him (House). 

Jones talked to House about the business and House drove him around as they looked at a possible grow site. Thereafter, Jones reached out to friend Roddy White and urged him to come aboard for “an opportunity in the cannabis space.” White, who Jones says trusts him greatly, agreed to do the venture.

Weeks later, House informed Jones and White that he had found a cultivator and his name was “Farmer John”. Jones and White flew back to Los Angeles, to meet the farmer. They were driven from Los Angeles by House and others to Farmer John’s Desert Hot Springs cultivation site. “After seeing the grow,” Jones explained, “they knew” Farmer John “was the man for the job.” After that, those present went into the farmer’s office “and started to negotiate the percentages and how much it would cost to build out and for him to grow the product.”

Sometime after Genetixs LLC was formed in California in March 2020 by House, Jones and White (using the Mississippi LLC, which had been formed in February 2020 for the cannabis deal) invested three million dollars in Genetixs.” 

Read more

Lack of Planning at the Business Formation Stage

The salacious allegations have spread across sports and cannabis platforms, often with huge chunks of the charging document presented as if the allegations are true. Paul Kuharsky, an all-things-NFL-commentator, was interviewed on a sports program in which, in pertinent part, he reminded the viewers, that the story alleged “if true . . . is not a good look for sure” for the sports figures. Kuharsky also added the caution that, in America, “anyone can sue for anything” and that what is happening “could be a sour grapes scenario.”

Sour grapes is an understatement. A big part of the story in the lead up to the July complaint has been ignored: there were two related lawsuits being litigated in different courtrooms in the same courthouse involving overlapping characters and company entities.

Surely, that earlier lawsuit that Jones and White (as SLW Holdings) filed in May 2021 against Genetixs’ management is what prompted Genetixs to alert the world in a publicly filed civil complaint that there was a dispute between grow house partners.

The NFL players, two months before the July lawsuit in which they ended up as defendants, hired a two-man Los Angeles law firm and went to court. Without notifying their fellow Genetixs business partners, Jones and White asked a judge in Los Angeles Superior Court to intervene in the grow house business operation. The players (who had soured on their investment) tried to wrest control of Genetixs from the LLC principal member, Lamarr House (“the Chairman”). House, who was aligned with partners who were not Jones and White, collectively directed a majority interest of the LLC membership units (akin to shares in a corporation) in Genetixs.

Roddy White, in an under-oath declaration filed as part of the May 2021 lawsuit, informed the court that he had no idea that people involved in the operation of Genetixs had been convicted of fraud crimes and “of federal heroin trafficking.” White emphatically declared that had we [Jones and I] known this “we certainly would not have invested $3,000,000 with them.” 

The players’ lawyers asked for a temporary restraining order (TRO), a preliminary injunction, and sought to expel members from Genetixs’ management and operations. In the May 2021 lawsuit, Jones and White claimed that fellow grow operation members, especially House, who they all had installed as the principal LLC manager, had breached their fiduciary duties to the business. They further asserted that some involved in the business had criminal records, and that unfair business practices were resulting in ruining the cannabis business.

Although the court initially granted the TRO as a way to maintain the status quo until she heard from the other side (to include House and other Genetixs employees), the restraining order was ultimately vacated. A portion of the court’s July 8, 2021 order in the May 2021 case states: “Having considered Plaintiff’s probability of prevailing and the balance of harms, the court denies the preliminary injunction.”

The reasons? The court ruled, in part, that some parties to the lawsuit had not been properly served by Jones and White’s lawyers as well as that the player-plaintiffs had not satisfactorily explained how the operations at the grow house and its alleged personnel issues caused Jones and White quantifiable damages (which the law requires for the kind of equitable court action that they had requested.)

A Corporate or LLC Agreement is Not a Cannabis Business Plan

Arguably the most significant aspect of the White and Jones lawsuit, which influenced the court’s decision to not force any management changes or expel any members, was that the very filing of Jones and White’s lawsuit was barred by the terms of Genetixs’ LLC operating agreement.

Genetixs’ 38-page operating agreement contained pages boilerplate and arcane LLC-related legal language with little specifically related to a cannabis cultivation business. Yet, White, House, and the other Genetixs members did execute it.

The operating agreement contained a curious attachment labeled Exhibit A. There, on a half-page, was the chart alluded to in Jones’ declaration—the part where they negotiated ownership percentages in Farmer John’s office. Exhibit A showed what each of Genetixs’ member-partners had provided to the business in exchange for shares in the grow house business. Only one member put in cash, and specifically noted was the number “$700,000+.” This was the initial capital provided to the Genetixs operation by White and Jones as SLW Holdings. Beside the name of every other member-partner were the words “sweat equity” or some other kind of intangible such as “expertise.”

Who got how many shares in exchange for what seems to have been the primary focus of Genetixs’ owners. Failing to read, understand, and tailor an operating agreement and neglecting to craft a detailed and thorough business plan, can easily lead to being tossed out of court. And this happened here. The Genetixs operating agreement contained a provision that no decisions about business affairs could be made unilaterally by a member. An agreement would be needed by “an affirmative vote” of the members or with the consent of those with a majority interest.

Once the move for injunctive relief was intercepted by the court on July 8, 2021, with the denial of the permanent injunction and the lifting the TRO, some of Genetixs’ operators (who had been sued by Jones and White) decided to file their own lawsuit against the players. Genetixs would go big and name Jones, White, and others individually, as well as SLW Holdings in their counter lawsuit.

On July 21, the NFL stars had become the defendants, and the sports and cannabis news feed world went into overdrive.

Without a PR team in place, the first story to catch the public’s eye about the NFL players involvement in a Desert Hot Springs grow site was the version of the events spelled out in the Genetixs lawsuit. Even though a lawyer could read the complaint and see that the players were not directly or personally involved in misconduct, the drafting of the legal instrument accuses all the civil defendants of the same conduct, and the attendant news coverage made it appear that the players had been involved in nefarious civil (and suggestively criminal) activity.

No Quick End In Sight For The Players

Civil litigation with two coexisting cases (the earlier May 2021 case has new motions for that judge to consider filed by, among other people, the NFL players’ lawyers) and the cringeworthy July 2021 allegations will continue to get much attention because of the combination of celebrity, sports, and cannabis. Also, since it was filed in the vast county of Los Angeles, home to some ten million residents, with state court judges having heavy case dockets and carrying many complex cases, the case will likely persist for years.

But the biggest reason it will take so long for the case to conclude is the amount of money alleged to have been squandered, specifically over $12 million in product or cash, as well as the removal from the site of expensive cultivation and extraction equipment.

Lawsuits can be dismissed “on the papers” if the legal action fails on its face to state a claim. Not here. Genetixs’ lengthy complaint more than amply states a claim (in fact, many claims). These unproven factual assertions could mean big money judgment for the folks bringing the lawsuit if proven in a court of law.

The Los Angeles Superior Court judge assigned to the Genetixs case is former federal prosecutor Barbara Scheper, who handled, among other things at the Los Angeles U.S. Attorney’s Office, complex white-collar crimes. She knows fraud and even when the typical motions to dismiss are filed, will likely let the case proceed to the discovery phase. This means each side will be subpoenaing the other side and other ancillary witnesses for testimony and documents. Then, the forensic accountants on both sides will assess how much money the business generated, how much, if any, was removed, and where the money (mostly cash) went. As forensic accountant Marion Wickersham of Forensic Resolutions, Inc., often opines on cannabis business education panels, “Cash can be tough to trace but we examiners have our ways.”

Takeaways for Cannabis Cultivation Businesses

No doubt that this case is convoluted, but there are clear lessons to be gleaned for cannabis business owners:

  • Choose business partners wisely. Vet them to include background and resume verification checks.
  • Do not invest money with any person or entity that has no seasoned and experienced management team in cannabis.
  • Be wary of investing anywhere which is geographically too far away to drive over and do a spontaneous inspection of the premises.
  • If you are planning to get in and stay in the cannabis business, have experienced civil practice lawyers (often current or former “big law” complex civil practice litigators now doing niche and focused cannabis work who have a roster of lawyers who understand and actually practice in civil cannabis law.)
  • Know this maxim: A corporate or LLC formation document is not a detailed cannabis business plan. Understand that the latter is typically needed for investors, and often must be submitted as an attachment to state and town licensing applications.

Plus, based on the Genetixs’ saga which concerns investing and operating a cannabis cultivation business, the cannabis business participants would be wise to hire, consult with and create a legal team that should include, but is not limited to, lawyers who have direct experience in:

  • Cannabis corporate/LLC/partnership/company formation
  • Cannabis licensure (for both states, U.S. territories and towns for both horizontal and vertically integrated operations)
  • Real estate and rental premises acquisition specific to cannabis businesses
  • Cannabis security systems to include cameras, logs, key card systems, guards, and employee apparel restrictions (for example, bans on clothes with pockets and pre and post work apparel and purse and backpack searches)
  • Cannabis tax, accounting, and books and records system expertise for IRS 280E federal compliance
  • Cannabis product tagging and tracking, seed-to-sale requirements
  • Cannabis and banking (to include those with expertise in how to properly safeguard and report what is still overwhelming a cash-based business due to the ever-present federal illegality of cannabis)
  • Cannabis employment and personnel practices to include expertise in background checks, drug testing, felon, and misdemeanor licensing exclusion provisions in each state of operation, as well as conviction expungement practices, and
  • Cannabis and insurance to include coverage for employee theft, break-ins as well as personal injury and costs of employees being prosecuted for workplace activities.

And as exemplified by this sordid cannabis business tale, the investor/business person’s team must include lawyers who understand and have had significant experience in drafting and specifically tailoring both cannabis operating agreements and cannabis-focused business plans.

Additionally, any successful cannabis business must have experienced forensic accountants on hand—certified public accountants who have worked with cannabis businesses, not just friends or bookkeepers who know how to input cash on an Excel spreadsheet.

And with reputation devastation one lawsuit away for anyone involved in cannabis, cannabis businesses (especially those in which public figures are involved) must have people on the team who have worked in cannabis public relations and crisis management.

Summing Up

Investing in cannabis businesses comes with significant risk, but for the handsomely capitalized (those who can lose money without losing much sleep) there can be great rewards. Had the sports figured treated their investment and participation differently, the outcome and duration of the litigation as well as “their spin” in the public eye would likely have been different.

One hopes Julio Jones who missed practice with the Atlanta Falcons in the first week of August, will soon have better days. With the right combination of expertise by his side or at his disposal he might just be able to change the odds in the game.

Julie A. Werner-Simon is a former federal prosecutor, now law professor adjunct and cannabis legal analyst at Drexel University’s Kline School of Law and the LeBow School of Business.

Filed Under: Cannabis News

Georgia’s Small Farmers Shut Out During ‘Secretive’ Cannabis Licensing Process, Advocate Says

August 16, 2021 by CBD OIL

After years of regulatory limbo that allowed registered patients in Georgia to possess—but not purchase—low-THC cannabis oil, the state has established a regulated market and has licensed six businesses to produce and sell the oil.

However, some industry stakeholders question the state’s licensing process and the businesses that ultimately won the right to operate in Georgia’s market.

“The process was relatively secretive for these companies to go out and apply for and receive these licenses,” Ryan Ralston, executive director of Peachtree NORML, told Cannabis Business Times and Cannabis Dispensary.

In 2015, Georgia legalized the possession of cannabis oil containing a maximum of 5% THC. In 2019, Gov. Brian Kemp signed a bill that legalized the production and sale of low-THC cannabis oil in the state, and Ralston said Peachtree NORML followed this legislation closely.

“One of the things that really stuck out to us was the fact that if a grower was going to apply for a Class I or a Class II license, right off the bat, they were going to have to be willing to waive their Fourth Amendment rights,” he said. “Basically, if you were going to operate as a dispensary, you had to sign a Fourth Amendment waiver, allowing local, state, and federal officials and law enforcement officials at any given time to enter your property without a warrant and search your property. That was one of the initial red flags on the legislation that we opposed.”

Another requirement, Ralston added, was that applicants must have upwards of $1.5 million in cash on hand to qualify for a license.

“Basically, what the legislation allowed for was bigger conglomerates to come into Georgia and not [allow] the smaller growers and smaller farmers [to produce] the low-THC oil here in Georgia,” he said.

Many smaller farmers have been cultivating hemp in the state since the passage of the 2014 Farm Bill, Ralston said, and while they may have the infrastructure needed to grow cannabis and produce the low-THC oil, many did not have the required cash on hand to apply for a license.

“If you think about it, 80% of Georgia’s economy is based on agriculture,” Ralston said. “You’re basically shutting out the Georgia farmer, and you’re allowing bigger companies to come in and start buying up land and buying up production, when in fact the smaller business operator has been doing it for more than a decade.”

Sixty-nine companies applied for Georgia’s six cannabis licenses, which were ultimately awarded to Trulieve GA Inc., Botanical Sciences LLC, FFD GA Holdings, TheraTrue Georgia LLC, Natures GA LLC and Treevana Remedy Inc.

Trulieve GA Inc., an affiliate of Florida-based Trulieve Cannabis Corp., and Botanical Sciences LLC, a company located in Glennville, won Class I licenses to grow up to 100,000 square feet of medical cannabis, while the other four companies secured Class II licenses to cultivate up to 50,000 square feet.

Each licensee will be allowed to open five dispensaries to sell their low-THC cannabis oil, which can be recommended to patients for a host of qualifying conditions, including cancer, seizure disorders and multiple sclerosis.

The licensing process and the licensees themselves have been under scrutiny in the weeks since the licenses were awarded.

The Atlanta Journal-Constitution points out in a recent report that medical cannabis patients and advocates are questioning how these six companies were chosen following what the news outlet calls a “competitive but secretive selection process by the Georgia Access to Medical Cannabis Commission.”

Also receiving industry backlash is the announcement that former Georgia Congressman and Health and Human Services Secretary Tom Price is serving on Botanical Sciences’ board of directors, despite his history of opposition to cannabis policy reform.

“To have a guy who fought so diligently against everything we’ve worked so hard to accomplish here in Georgia and then receive a license, it was a tough pill to swallow,” Allen Peake, a former state representative who helped win the passage of Georgia’s medical cannabis law, and who was denied a license, told the Atlanta Journal-Constitution. “It’s the height of hypocrisy.”

Fifteen rejected applicants have filed protests against the licensing process, the news outlet reported, and Ralston said he foresees lawsuits on the horizon, which could cause further delays in the rollout of the program.

“It’s kind of been a bureaucratic nightmare down here,” he said.

Once the dust settles and licensing is finalized, licensees will have one year to begin operations, meaning that patients are still at least 12 months out from accessing the low-THC cannabis oil.

“It’s just further frustrating to Georgians, specifically to those who are sick, who are suffering and who are potentially dying, and they don’t have access to the low-THC oil,” he said.

The state could continue to struggle with supply to meet patient demand even after the businesses are up and running, Ralston added, especially since each dispensary is only permitted to serve a maximum of 20,000 patients under state law.

“They’ll be geographically scattered throughout the state, but they’ll only be allowed to take care of upwards of 20,000 patients per dispensary, so once … that particular dispensary reaches its allotted number of patients, Georgians are going to be turned away or they’re going to be forced to travel to a dispensary that may be three to five hours away,” he said. “It’s just going to further complicate the issue.”

Georgia currently has roughly 20,000 registered patients, and Ralston expects this number to grow rapidly as the program rolls out.

“What you’re going to see is the demand for these cards skyrocket over the next probably six to eight months, and I just don’t foresee the dispensaries being able to support that,” he said.

Filed Under: Cannabis News

HUB International Announces Evan Stait as Canada Cannabis Specialty Leader

August 16, 2021 by CBD OIL

It’s not quite worth its weight in gold, but there’s a cannabis rush going on in Oklahoma—for both patients and businesses—and there’s no sign of slowing down.

The number of active patients grew by more than 46,000 during the past year, representing a 14% increase to the current total of nearly 376,000 patients, according to a licensing report released by the Oklahoma Medical Marijuana Authority (OMMA) on Aug. 2. That means roughly 9.4% of the state’s population is actively registered in the medical cannabis program.

Also in the report, Oklahoma has 469 more licensed businesses than this time last year, bringing the active total to 12,598. That list includes 8,625 growers, 2,325 dispensaries and 1,523 processors, in addition to transporters, laboratories and other licensees.

“Oklahoma has one of the largest programs in the country,” the Marijuana Policy Project stated in a policy update released May 3. “Despite the pandemic, the medical cannabis market has been booming, and the Oklahoma Medical Marijuana Authority reports that the state collected over $127 million in state and local taxes from medical cannabis in 2020.”

After voters approved State Question 788 to legalized medical cannabis on June 26, 2018, Oklahoma became the quickest state in the nation to implement an effective medical cannabis law.

Less than two months following S.Q. 788’s passage, Oklahoma opened its application process for businesses and patients—OMMA received 366 patient applications and 205 commercial applications in the first hour of opening its portal. In all, 23 people were approved for medical cannabis licenses on the first day. The first sales began about a month after that.

While the state’s program has continued to grow under unlimited licenses, the Oklahoma Legislature recently passed a bill that would direct the OMMA to conduct on-site compliance inspections with medical cannabis dispensary, processor and grower licensees beginning Sept. 1. The purpose of the compliance directive is to ensure business licensees are actively operating or working toward operational status, according to the bill’s text. Upon expiration of a grace period, the OMMA can terminate any licenses if certain standards are not met.

In addition, the legislation, which Gov. Kevin Stitt approved May 18, also requires medical cannabis businesses to complete an ownership attestation—disclosing the existence of any foreign financial interests and the identity of such ownership, if applicable—with the Oklahoma Bureau of Narcotics and Dangerous Drugs (OBNDD) by Aug. 30. New licensees have 60 days to comply. Failure to do so will result in the loss of OMMA licenses.

To apply for a license in Oklahoma, 75% of the ownership must be held by someone who has lived in the state for a minimum of two years; however, illicit operations have emerged through a loophole—companies are hiring “ghost owners” to obtain licenses. That’s one reason some state lawmakers have drafted new regulations for the industry.

RELATED: Struggles With Illicit Cannabis Operations Affecting Local Growers

The House sponsor for Senate Bill 1033, Republican Rep. Scott Fetgatter backed the legislation because it allows the OBNDD and the OMMA to enter into agreements to hire more agents, he said in a press release. The governor approved the bill on May 28.

“In 2018, we bought the ticket and took the ride when it came to medical marijuana in Oklahoma,” Fetgatter said. “There weren’t many regulations and stakeholders on all sides of the issue have been looking for structure. This industry has blossomed over the past three years, and we have been working to make sure there are structures in place to regulate and help give guidance to those working within it. I’m proud that this session we were able to pass so many important pieces of legislation that do just that.”

Despite illegal operations, Oklahoma collected $90.7 million in medical cannabis taxes during the first seven months of 2021, including $12.6 million in July, according to OMMA. At that pace, Oklahoma will surpass $155 million of medical cannabis taxes collected this year—a 22% increase from 2020.

While Oklahoma was the 30th state to legalize medical cannabis in 2018, it now has one of the largest programs in the country. And it’s still growing.

Filed Under: Cannabis News

Scottsdale Research Institute’s Sue Sisley Announced as Day 2 Keynote at Cannabis Conference 2021

August 16, 2021 by CBD OIL

LAS VEGAS, NV [August 16, 2021] – Cannabis Conference, produced by parent company GIE Media Inc. and industry-leading Cannabis Business Times, Cannabis Dispensary, and Hemp Grower magazines, announces today President of Scottsdale Research Institute (SRI) Sue Sisley, MD, as the keynote speaker on Day 2 of its annual event, to take place Aug. 24-26, 2021, at Paris Las Vegas Hotel & Casino.

During the keynote session titled “Sue’n the DEA: The Story of a Cannabis Research Breakthrough,” Dr. Sisley—a pioneering medical cannabis researcher and volunteer medical director for more than 40 state cannabis licenses—will share her journey on navigating scientific and legal complexities of medical cannabis research. Dr. Sisley will highlight cutting-edge discoveries from her roles in cannabis studies for pain management and post-traumatic stress disorder (PTSD), as a substitution therapy for opioids, and more.

Dr. Sisley will also explain how she and two lawyers took on the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) through litigation and succeeded—eliminating the 52-year-old government-enforced research monopoly and eventually acquiring a Schedule I research license to cultivate cannabis flower for Food and Drug Administration (FDA)-approved clinical trials.

The Day 2 keynote session will take place on Wednesday, Aug. 25 from 11 a.m. – 12 p.m. PT.

“In a year when the potential for federal legalization has come front and center for this now-deemed essential business, it’s an especially exciting time to be highlighting the part my team and I have played in pushing the boundaries of what is truly possible with medical cannabis,” Sisley said. “I’m looking forward to sharing my story with the plant-touching businesses that work so hard to make medical cannabis a reality for people and exploring the ways in which we can collaborate together in furtherance of our industry goals.”   

“We couldn’t be more thrilled to host Dr. Sisley at Cannabis Conference 2021 as our Day 2 keynote,” said Cannabis Conference Programming Director Cassie Neiden Tomaselli. “Dr. Sisley is the definition of a cannabis trailblazer. Her passion and perseverance for the plant, and the ways in which she and her teams have fought to prove its medical efficacy and legitimacy, are sure to inspire valuable takeaways for both industry veterans and new entrants alike.”

More information about Cannabis Conference, including sessions, speakers, exhibitors and FAQs, can be found at www.CannabisConference.com. Rates will increase August 20, 2021. Click hereto review pricing and to register.

 

About Cannabis Conference

Cannabis Conference 2021, presented by the award-winning Cannabis Business Times, Cannabis Dispensary, and Hemp Grower media brands, is the leading educational provider for plant-touching businesses in the legal cannabis and hemp markets. The three-day event will take place at Paris Las Vegas Hotel & Casino in Las Vegas, Nev., on Aug. 24-26, 2021. The Cannabis Conference exhibition hall will feature 170+ industry-leading technologies, solutions and services for the professional cannabis cultivator and retail businesses. For more information, visit www.CannabisConference.com.

About GIE Media

GIE Media was founded in 1980 and has grown over 41 years into a leading marketing and communications business-to-business media company serving 17 industries—including the horticulture industry through its Horticulture Group (Greenhouse Management, Produce Grower, Nursery Management, Garden Center, Cannabis Business Times, Cannabis Dispensary and Hemp Grower). The company employs nearly 100 editors, publishers, sales representatives, marketers and other professionals. For more information, visit www.GIEMedia.com.

Filed Under: Cannabis News

Coalition to Regulate Marijuana Like Alcohol Resubmits Summary Language in Ohio

August 16, 2021 by CBD OIL

It’s not quite worth its weight in gold, but there’s a cannabis rush going on in Oklahoma—for both patients and businesses—and there’s no sign of slowing down.

The number of active patients grew by more than 46,000 during the past year, representing a 14% increase to the current total of nearly 376,000 patients, according to a licensing report released by the Oklahoma Medical Marijuana Authority (OMMA) on Aug. 2. That means roughly 9.4% of the state’s population is actively registered in the medical cannabis program.

Also in the report, Oklahoma has 469 more licensed businesses than this time last year, bringing the active total to 12,598. That list includes 8,625 growers, 2,325 dispensaries and 1,523 processors, in addition to transporters, laboratories and other licensees.

“Oklahoma has one of the largest programs in the country,” the Marijuana Policy Project stated in a policy update released May 3. “Despite the pandemic, the medical cannabis market has been booming, and the Oklahoma Medical Marijuana Authority reports that the state collected over $127 million in state and local taxes from medical cannabis in 2020.”

After voters approved State Question 788 to legalized medical cannabis on June 26, 2018, Oklahoma became the quickest state in the nation to implement an effective medical cannabis law.

Less than two months following S.Q. 788’s passage, Oklahoma opened its application process for businesses and patients—OMMA received 366 patient applications and 205 commercial applications in the first hour of opening its portal. In all, 23 people were approved for medical cannabis licenses on the first day. The first sales began about a month after that.

While the state’s program has continued to grow under unlimited licenses, the Oklahoma Legislature recently passed a bill that would direct the OMMA to conduct on-site compliance inspections with medical cannabis dispensary, processor and grower licensees beginning Sept. 1. The purpose of the compliance directive is to ensure business licensees are actively operating or working toward operational status, according to the bill’s text. Upon expiration of a grace period, the OMMA can terminate any licenses if certain standards are not met.

In addition, the legislation, which Gov. Kevin Stitt approved May 18, also requires medical cannabis businesses to complete an ownership attestation—disclosing the existence of any foreign financial interests and the identity of such ownership, if applicable—with the Oklahoma Bureau of Narcotics and Dangerous Drugs (OBNDD) by Aug. 30. New licensees have 60 days to comply. Failure to do so will result in the loss of OMMA licenses.

To apply for a license in Oklahoma, 75% of the ownership must be held by someone who has lived in the state for a minimum of two years; however, illicit operations have emerged through a loophole—companies are hiring “ghost owners” to obtain licenses. That’s one reason some state lawmakers have drafted new regulations for the industry.

RELATED: Struggles With Illicit Cannabis Operations Affecting Local Growers

The House sponsor for Senate Bill 1033, Republican Rep. Scott Fetgatter backed the legislation because it allows the OBNDD and the OMMA to enter into agreements to hire more agents, he said in a press release. The governor approved the bill on May 28.

“In 2018, we bought the ticket and took the ride when it came to medical marijuana in Oklahoma,” Fetgatter said. “There weren’t many regulations and stakeholders on all sides of the issue have been looking for structure. This industry has blossomed over the past three years, and we have been working to make sure there are structures in place to regulate and help give guidance to those working within it. I’m proud that this session we were able to pass so many important pieces of legislation that do just that.”

Despite illegal operations, Oklahoma collected $90.7 million in medical cannabis taxes during the first seven months of 2021, including $12.6 million in July, according to OMMA. At that pace, Oklahoma will surpass $155 million of medical cannabis taxes collected this year—a 22% increase from 2020.

While Oklahoma was the 30th state to legalize medical cannabis in 2018, it now has one of the largest programs in the country. And it’s still growing.

Filed Under: Cannabis News

CBD’s paw print in the cannabinoid world

August 15, 2021 by CBD OIL

As people discover the benefits of the non-psychoactive cannabinoid cannabidiol (CBD), they wonder if it could benefit their animal companions as well. However, human and animal bodies process cannabinoids differently [3]. So what do we really know about the paw print of CBD in the cannabinoid world?

Important points

  • If you give your dog a larger single dose of CBD, the effects won’t get any stronger [3].
  • Dogs get more CBD from an oral dose than humans [3].
  • Dogs and cats require different dosages of CBD [1].
  • Traces of THC in CBD products can have negative effects on pets [4].
  • Always speak to your veterinarian before giving CBD to your pet.

Research on CBD for dogs was published back in 1988 [3]. This study tested pure CBD given intravenously or orally to dogs. The researchers found that the effects of CBD in dogs were not dose-dependent. This means that if you give the dog more CBD, you won’t necessarily get more potency. They also found that oral bioavailability (the amount of active CBD in the body) was 13% to 19%, which is better absorption than humans.

People give CBD to dogs and cats for disorders related to anxiety, seizures, cancer, and pain [1]. A 2019 research paper explains that cats have a higher rate of oral absorption than dogs. Overall, CBD appears to be well tolerated by adult dogs, but less is known about CBD for cats. For this reason, it is extremely important to speak to your veterinarian before giving CBD products to your dog or cat. Only they can advise you on the correct dosage for your pet. Since CBD can have side effects and drug interactions, they can also tell you whether it is safe for your pet to take CBD.

Now that we’ve talked about CBD dosage for dogs and cats and how they absorb CBD, let’s consider whether CBD is actually beneficial for pets. In a 2018 study, dogs with osteoarthritis were given CBD oil and their pain level was assessed after four weeks [2]. Overall, the dog’s pain level appeared to be decreasing and its activity level improved. The dogs were also allowed to receive NSAIDs, fish oil, and / or glucosamine / chondroitin sulfate. This study is far from final, but it does give us the insight that when combined with standard veterinary treatment, CBD can improve dog health and reduce pain associated with osteoarthritis.

Finally, choosing the right CBD product for your pet is important. Your veterinarian is the most qualified person to make a recommendation. Much care needs to be taken as even traces of the psychoactive tetrahydrocannabinol (THC) can cause side effects to your dog. While most of the CBD side effects are mild, people can also tolerate THC better. A 2020 study observed that dogs given CBD containing traces of THC experienced side effects such as lethargy, hypothermia, and ataxia (loss of complete control over body movements). [4]. So watch out for such side effects, opt for CBD isolate for pets and always speak to your veterinarian!

References

1- Deabold KA, Schwark WS, Wolf L, Wakshlag JJ. Single-dose pharmacokinetics and preliminary safety assessment of the use of high-CBD hemp nutraceutical in healthy dogs and cats. Animals. 2019; 9 (10): 832. doi: 10.3390 / ani9100832

2- Gamble LJ, Boesch JM, Frye CW et al. Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Limits in Veterinary Science. 2018; 5. doi: 10.3389 / fvets.2018.00165 Retrieved August 12, 2021. https://internal-journal.frontiersin.org/articles/10.3389/fvets.2018.00165/full#h3

3- Samara E., M. Bialer, R. Mechoulam. Pharmacokinetics of cannabidiol in dogs. Drug metabolism and disposition. 1988; 16 (3): 469-472. Retrieved August 12, 2021. https://dmd.aspetjournals.org/content/16/3/469.short

4- Vaughn D, Kulpa J, Paulionis L. Preliminary study of the safety of escalating cannabinoid doses in healthy dogs. Limits in Veterinary Science. 2020; 7. doi: 10.3389 / fvets.2020.00051, accessed August 12, 2021. https://www.frontiersin.org/articles/10.3389/fvets.2020.00051/full

picture: https://www.pexels.com/photo/man-person-love-people-6235648/ by Tima Miroshnichenko from Pexels.com

Filed Under: CBD Health

NIST study to standardize cannabis tests

August 15, 2021 by CBD OIL

Hemp and cannabis strains have striking similarities. However, they differ in the amount of THC that is in each one.

THC has psychoactive or mind altering abilities. As a result, it is classified in Appendix 1 and is considered illegal under federal law. Since hemp only contains traces of THC, it does not fall into this category. If anything, it was fully legalized at the federal level with the passage of the Agricultural Act 2018.

The percentage of THC in hemp is his make or break; cross the 0.3% threshold and officially you are dealing with marijuana. Depending on your state laws, you could run into big problems!

When you get the exact amount of THC in a sample, the rubber hits the road. Most laboratories are not equipped with the proper techniques to do this effectively. This difference in quantification and testing methods makes it difficult to standardize in the industry. This is an area that needs to be investigated.

The National Institute of Standards and Technology (NIST) just released the results of a study designed to help laboratories get accurate THC measurements in samples for informed decision-making. This goes hand in hand with their quality assurance program under the CannaQAP brand. The results that have been anonymized were published on the NIST website in July. The reason for maintaining anonymity was to encourage laboratories to participate without worrying about “failing” or “passing” the test.

Hemp samples were prepared with exact amounts of THC, CBD, and other compounds and sent to various laboratories for testing. One hundred and sixteen laboratories participated, including commercial laboratories performing cannabis testing and academic chemical testing laboratories. Almost 83 percent of the participating laboratories sent data to the NIST. The labs measured various cannabinoids (and pollutants) and sent the results to the NIST lab for comparison.

Although the results fluctuated significantly, the researchers said this was normal and to be expected:

“The entire industry does quite well with the target values.”

With this study, NIST hopes to create a learning opportunity for cannabis testing laboratories and help standardize testing methods in the industry. NIST will also use the results to determine the methods and practices that will work best.

Finally, NIST hopes to create a reference material for hemp that will serve as an industry guide.

Image source

https://cbdhealthandwellness.net/2021/08/02/does-cbd-athletic-tape-work/

Filed Under: CBD Health

Get the Skinny On CBD Summer Skincare

August 15, 2021 by CBD OIL

Cannabidiol (CBD) topicals are nothing new, but with summer in full swing they are becoming very popular as part of a comprehensive skin care regimen, especially when it comes to protecting the skin from the potentially harmful UV rays. It can be dangerous to leave your skin unprotected when you are in the sun for a long time, especially for people with particularly sensitive skin.

CBD has been linked to a seemingly endless list of benefits, and skin protection is just one of them.

The anti-inflammatory properties of CBD for better skin health

For starters, CBD has anti-inflammatory properties that can help keep skin from becoming inflamed from the sun’s rays. [1] And when combined with other active ingredients common in sunscreen products, like zinc oxide, CBD can work wonders to keep skin healthy, hydrated, and protected from the sun.

In fact, it’s the anti-inflammatory properties of CBD that have linked the cannabinoid to a host of health benefits, including promoting better skin. [2] The interaction of CBD with the endocannabinoid system in the body allows it to act at the cellular level to reduce inflammation that is not only at the core of sunburns after a day outdoors, but also eczema, acne, and other skin conditions that cause flare-ups cause due to an underlying inflammation.

CBD skin care products are also often fortified with essential oils to add another protective layer to the skin while adding an aromatic component to the product.

Even in summer, skin care should focus on moisturizing care. Hence, moisturizers should be applied regularly to avoid dry skin, which tends to accompany a day in the sun. Applying a moisturizer under the sunscreen can keep the skin well hydrated while the sunscreen protects against UV rays.

There are more and more moisturizers out there that are already fortified with CBD. However, if you already have a favorite that you use regularly, adding a few drops of CBD oil can help boost the skin’s moisturizing and moisturizing properties.

Lip protection with CBD

In addition to protecting the skin on the face and body, it is important not to ignore the lips. There are several lip products that have both moisturizing properties and added SPF protection from the sun.

But many more are being launched that are fortified with CBD oil to help nourish the lips and prevent problems like dryness, cracking, and more serious sun-related issues. Again, CBD lip products tend to contain other ingredients to maximize protection and hydration, including beeswax and essential oils.

Enjoy the summer safely with high quality CBD infused skin care products.

Image source: Igor Link from Pixabay

References:

  1. Nagarkatti, P., et al., “Cannabinoids as novel anti-inflammatory drugs“Future Med Chem., October 2009, 1 (7): 1333-1349.
  1. Baswan, SM, et al. “Cannabidiol (CBD) has therapeutic potential for skin health and skin conditions“, Clin Cosmet Investig Dermatol., 2020, 13: 927-942.

Filed Under: CBD Health

FDA Sends Strong Signal Opposing CBD Dietary Supplement Regulation: Week in Review

August 14, 2021 by CBD OIL

It’s not quite worth its weight in gold, but there’s a cannabis rush going on in Oklahoma—for both patients and businesses—and there’s no sign of slowing down.

The number of active patients grew by more than 46,000 during the past year, representing a 14% increase to the current total of nearly 376,000 patients, according to a licensing report released by the Oklahoma Medical Marijuana Authority (OMMA) on Aug. 2. That means roughly 9.4% of the state’s population is actively registered in the medical cannabis program.

Also in the report, Oklahoma has 469 more licensed businesses than this time last year, bringing the active total to 12,598. That list includes 8,625 growers, 2,325 dispensaries and 1,523 processors, in addition to transporters, laboratories and other licensees.

“Oklahoma has one of the largest programs in the country,” the Marijuana Policy Project stated in a policy update released May 3. “Despite the pandemic, the medical cannabis market has been booming, and the Oklahoma Medical Marijuana Authority reports that the state collected over $127 million in state and local taxes from medical cannabis in 2020.”

After voters approved State Question 788 to legalized medical cannabis on June 26, 2018, Oklahoma became the quickest state in the nation to implement an effective medical cannabis law.

Less than two months following S.Q. 788’s passage, Oklahoma opened its application process for businesses and patients—OMMA received 366 patient applications and 205 commercial applications in the first hour of opening its portal. In all, 23 people were approved for medical cannabis licenses on the first day. The first sales began about a month after that.

While the state’s program has continued to grow under unlimited licenses, the Oklahoma Legislature recently passed a bill that would direct the OMMA to conduct on-site compliance inspections with medical cannabis dispensary, processor and grower licensees beginning Sept. 1. The purpose of the compliance directive is to ensure business licensees are actively operating or working toward operational status, according to the bill’s text. Upon expiration of a grace period, the OMMA can terminate any licenses if certain standards are not met.

In addition, the legislation, which Gov. Kevin Stitt approved May 18, also requires medical cannabis businesses to complete an ownership attestation—disclosing the existence of any foreign financial interests and the identity of such ownership, if applicable—with the Oklahoma Bureau of Narcotics and Dangerous Drugs (OBNDD) by Aug. 30. New licensees have 60 days to comply. Failure to do so will result in the loss of OMMA licenses.

To apply for a license in Oklahoma, 75% of the ownership must be held by someone who has lived in the state for a minimum of two years; however, illicit operations have emerged through a loophole—companies are hiring “ghost owners” to obtain licenses. That’s one reason some state lawmakers have drafted new regulations for the industry.

RELATED: Struggles With Illicit Cannabis Operations Affecting Local Growers

The House sponsor for Senate Bill 1033, Republican Rep. Scott Fetgatter backed the legislation because it allows the OBNDD and the OMMA to enter into agreements to hire more agents, he said in a press release. The governor approved the bill on May 28.

“In 2018, we bought the ticket and took the ride when it came to medical marijuana in Oklahoma,” Fetgatter said. “There weren’t many regulations and stakeholders on all sides of the issue have been looking for structure. This industry has blossomed over the past three years, and we have been working to make sure there are structures in place to regulate and help give guidance to those working within it. I’m proud that this session we were able to pass so many important pieces of legislation that do just that.”

Despite illegal operations, Oklahoma collected $90.7 million in medical cannabis taxes during the first seven months of 2021, including $12.6 million in July, according to OMMA. At that pace, Oklahoma will surpass $155 million of medical cannabis taxes collected this year—a 22% increase from 2020.

While Oklahoma was the 30th state to legalize medical cannabis in 2018, it now has one of the largest programs in the country. And it’s still growing.

Filed Under: Cannabis News

Oklahoma’s Medical Cannabis Rush Continues

August 13, 2021 by CBD OIL

It’s not quite worth its weight in gold, but there’s a cannabis rush going on in Oklahoma—for both patients and businesses—and there’s no sign of slowing down.

The number of active patients grew by more than 46,000 during the past year, representing a 14% increase to the current total of nearly 376,000 patients, according to a licensing report released by the Oklahoma Medical Marijuana Authority (OMMA) on Aug. 2. That means roughly 9.4% of the state’s population is actively registered in the medical cannabis program.

Also in the report, Oklahoma has 469 more licensed businesses than this time last year, bringing the active total to 12,598. That list includes 8,625 growers, 2,325 dispensaries and 1,523 processors, in addition to transporters, laboratories and other licensees.

“Oklahoma has one of the largest programs in the country,” the Marijuana Policy Project stated in a policy update released May 3. “Despite the pandemic, the medical cannabis market has been booming, and the Oklahoma Medical Marijuana Authority reports that the state collected over $127 million in state and local taxes from medical cannabis in 2020.”

After voters approved State Question 788 to legalized medical cannabis on June 26, 2018, Oklahoma became the quickest state in the nation to implement an effective medical cannabis law.

Less than two months following S.Q. 788’s passage, Oklahoma opened its application process for businesses and patients—OMMA received 366 patient applications and 205 commercial applications in the first hour of opening its portal. In all, 23 people were approved for medical cannabis licenses on the first day. The first sales began about a month after that.

While the state’s program has continued to grow under unlimited licenses, the Oklahoma Legislature recently passed a bill that would direct the OMMA to conduct on-site compliance inspections with medical cannabis dispensary, processor and grower licensees beginning Sept. 1. The purpose of the compliance directive is to ensure business licensees are actively operating or working toward operational status, according to the bill’s text. Upon expiration of a grace period, the OMMA can terminate any licenses if certain standards are not met.

In addition, the legislation, which Gov. Kevin Stitt approved May 18, also requires medical cannabis businesses to complete an ownership attestation—disclosing the existence of any foreign financial interests and the identity of such ownership, if applicable—with the Oklahoma Bureau of Narcotics and Dangerous Drugs (OBNDD) by Aug. 30. New licensees have 60 days to comply. Failure to do so will result in the loss of OMMA licenses.

To apply for a license in Oklahoma, 75% of the ownership must be held by someone who has lived in the state for a minimum of two years; however, illicit operations have emerged through a loophole—companies are hiring “ghost owners” to obtain licenses. That’s one reason some state lawmakers have drafted new regulations for the industry.

RELATED: Struggles With Illicit Cannabis Operations Affecting Local Growers

The House sponsor for Senate Bill 1033, Republican Rep. Scott Fetgatter backed the legislation because it allows the OBNDD and the OMMA to enter into agreements to hire more agents, he said in a press release. The governor approved the bill on May 28.

“In 2018, we bought the ticket and took the ride when it came to medical marijuana in Oklahoma,” Fetgatter said. “There weren’t many regulations and stakeholders on all sides of the issue have been looking for structure. This industry has blossomed over the past three years, and we have been working to make sure there are structures in place to regulate and help give guidance to those working within it. I’m proud that this session we were able to pass so many important pieces of legislation that do just that.”

Despite illegal operations, Oklahoma collected $90.7 million in medical cannabis taxes during the first seven months of 2021, including $12.6 million in July, according to OMMA. At that pace, Oklahoma will surpass $155 million of medical cannabis taxes collected this year—a 22% increase from 2020.

While Oklahoma was the 30th state to legalize medical cannabis in 2018, it now has one of the largest programs in the country. And it’s still growing.

Filed Under: Cannabis News

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 9
  • Go to page 10
  • Go to page 11
  • Go to page 12
  • Go to page 13
  • Interim pages omitted …
  • Go to page 117
  • Go to Next Page »

Footer

  • Home
  • Privacy Policy
  • Terms of Service